Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma
Clinical trial NCT00258336 · UNKNOWN
Trial details
- NCT number
- NCT00258336
- Sponsor
- Favrille
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-08-01
- Primary completion
- 2009-11-01
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.